| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.1231 | 42 |
| GSM780708 | Untreated after 4 days (C2_1) | 50.3691 | 50 |
| GSM780709 | Untreated after 4 days (C3_1) | 54.5856 | 59 |
| GSM780719 | Untreated after 4 days (C1_2) | 56.904 | 62 |
| GSM780720 | Untreated after 4 days (C2_2) | 50.0816 | 49 |
| GSM780721 | Untreated after 4 days (C3_2) | 49.1093 | 45 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 53.1477 | 56 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 50.9136 | 51 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 48.8329 | 44 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 49.9493 | 48 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 51.8876 | 54 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 56.4806 | 61 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 49.1824 | 46 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 53.097 | 56 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 53.6259 | 57 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.2084 | 23 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 51.6067 | 53 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 51.8256 | 54 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 50.4468 | 50 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 50.9071 | 51 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 48.4151 | 43 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 50.407 | 50 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 51.5811 | 53 |